window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : April 24, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

Movers & Shakers

  • Clinical Development,Clinical Trials,Global health,Movers & Shakers,Partnerships & Funding,Research & Development

    Nucleus Network acquires Hammersmith Medicines Research to expand global early-phase clinical trial footprint

    Nucleus Network has acquired UK-based Hammersmith Medicines Research (HMR), a [...]

    August 5, 2025
  • Biologics & Biosimilars,Clinical Development,Drug Development,Movers & Shakers,Research & Development

    Meitheal strengthens leadership team with new chief medical officer and head of medical affairs

    Appointments reflect strategic focus on infectious disease and medical affairs [...]

    August 1, 2025
  • Clinical Development,Drug Delivery & Formulation,Drug Development,Movers & Shakers,Oncology,Precision medicine

    PhoreMost appoints Pfizer drug discovery veteran Dr Adam Gilbert to scientific advisory board

    Appointment strengthens expertise in targeted protein degradation as company advances [...]

    July 28, 2025
  • CDMOs & Manufacturing,Drug Delivery & Formulation,Global health,Movers & Shakers,Supply Chain & Logistics,Technology and platforms

    Colorcon expands global supply network with new pharmaceutical film coating facility in Malaysia

    Colorcon has officially opened a new pharmaceutical film coating manufacturing [...]

    July 25, 2025
  • CDMOs & Manufacturing,Drug Development,Movers & Shakers

    Abzena appoints Geoffrey Glass as CEO to drive next growth phase

    Abzena, the integrated CDMO and CRO specializing in complex biologics [...]

    July 22, 2025
  • Movers & Shakers

    Discover Pharma – Our first quarter

    We launched Discover Pharma to bring clarity, integrity, and relevance [...]

    June 30, 2025
  • Cell & Gene Therapy,Clinical Trials,Movers & Shakers,Rare Diseases

    Ascidian boosts RNA therapy push with key hire and expert board for Stargardt trial

    Ascidian Therapeutics has appointed Murray Abramson as chief development officer. [...]

    June 30, 2025
  • Movers & Shakers

    From Edelman to Inizio: Kelly Cusumano to shape pharma comms

    Inizio Evoke has appointed agency veteran Kelly Cusumano as Executive [...]

    June 27, 2025
  • Movers & Shakers

    Astoriom appoints Brittany Jackson as CFO to drive financial strategy and global growth

    Key leadership hire to support expansion in sample stability and [...]

    June 25, 2025
  • Movers & Shakers

    Phastar appoints industry veteran Billy Amzal as head of strategic consulting

    Biostatistics and real-world evidence expert joins global CRO to advance [...]

    June 25, 2025
Previous678Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • ProQR partners with Ginkgo Bioworks for AI-driven RNA editing development and forms advisory board
    Categories: Artificial Intelligence, Biotech, Drug Development, Drug discovery, Research & Development
  • Weite Oldenziel
    Ofichem unifies CDMO and pharmaceutical supply brands under single identity
    Categories: CDMOs & Manufacturing, Supply Chain & Logistics
  • DeepCyte raises $1.5M to advance single-cell AI toxicology platform for drug development
    Categories: Artificial Intelligence, Drug discovery, Funding, Technology and platforms
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top